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  Study	  objectives.	  	  Insomnia	  is	  a	  highly	  prevalent	  condition	  that	  constitutes	  a	  major	  public	  health	  and	  economic	  burden.	  However,	  little	  is	  known	  about	  the	  developmental	  etiology	  of	  adulthood	  insomnia.	  	  Design.	  	  We	  examined	  whether	  indicators	  of	  psychological	  vulnerability	  across	  multiple	  developmental	  periods	  (psychiatric	  diagnoses	  in	  young	  adulthood	  and	  adolescence,	  childhood	  behavioral	  problems,	  and	  familial	  psychiatric	  history)	  predicted	  subsequent	  insomnia	  in	  adulthood.	  	  	  Setting	  and	  participants.	  	  We	  used	  data	  from	  the	  ongoing	  Dunedin	  Multidisciplinary	  Health	  and	  Development	  Study,	  a	  population-­‐representative	  birth	  cohort	  study	  of	  1,037	  children	  in	  New	  Zealand	  who	  were	  followed	  prospectively	  from	  birth	  (1972–1973)	  through	  their	  fourth	  decade	  of	  life	  with	  a	  95%	  retention	  rate.	  	  	  Measurements.	  	  Insomnia	  was	  diagnosed	  at	  age	  38	  according	  to	  DSM-­‐IV	  criteria.	  Psychiatric	  diagnoses,	  behavioral	  problems,	  and	  family	  psychiatric	  histories	  were	  assessed	  between	  ages	  5	  and	  38.	  	  	  Results.	  In	  cross-­‐sectional	  analyses,	  insomnia	  was	  highly	  comorbid	  with	  multiple	  psychiatric	  disorders.	  	  After	  controlling	  for	  this	  concurrent	  comorbidity,	  our	  results	  showed	  that	  individuals	  who	  have	  family	  histories	  of	  depression	  or	  anxiety,	  and	  who	  manifest	  lifelong	  depression	  and	  anxiety	  beginning	  in	  childhood,	  are	  at	  uniquely	  high	  risk	  of	  age-­‐38	  insomnia.	  	  Other	  disorders	  did	  not	  predict	  adulthood	  insomnia.	  Conclusions.	  	  The	  link	  between	  lifelong	  depression	  and	  anxiety	  symptoms	  and	  adulthood	  insomnia	  calls	  for	  further	  studies	  to	  clarify	  the	  neurophysiological	  systems	  or	  behavioral	  conditioning	  processes	  that	  may	  underlie	  this	  association.	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INTRODUCTION	  	  Insomnia	  is	  a	  highly	  prevalent	  condition	  that	  affects	  10%	  to	  20%	  of	  adults	  and	  constitutes	  a	  major	  public	  health	  and	  economic	  burden.1-­‐5	  	  The	  pathogenesis	  of	  adult	  insomnia,	  however,	  is	  incompletely	  understood.	  	  Pre-­‐existing	  mental	  health	  problems	  appear	  to	  constitute	  one	  important	  risk	  indicator.	  	  Insomnia	  and	  other	  psychiatric	  disorders,	  particularly	  depression	  and	  anxiety,	  are	  highly	  comorbid	  in	  cross-­‐sectional	  samples.3,	  6,	  7	  	  The	  mechanisms	  underlying	  this	  comorbidity	  are	  still	  uncertain	  and	  likely	  to	  be	  complex	  in	  nature.	  	  Many	  studies	  show	  that	  individuals	  with	  insomnia	  are	  more	  likely	  to	  develop	  future	  psychiatric	  disorders.8-­‐10	  	  Researchers	  have	  also	  reported,	  however,	  that	  psychopathology	  –	  most	  notably	  the	  internalizing	  disorders	  of	  depression	  and	  anxiety	  –	  may	  manifest	  prior	  to	  and	  increase	  risk	  for	  the	  development	  of	  adult	  insomnia.11-­‐16	  	  	  	  	  	  This	  developmental	  vulnerability	  to	  insomnia	  may	  involve	  more	  psychopathologies,	  and	  begin	  earlier,	  than	  previous	  studies	  have	  been	  able	  to	  examine.	  	  Cross-­‐sectional	  associations	  have	  been	  reported	  between	  poor	  sleep	  and	  externalizing	  disorders,	  especially	  alcohol	  dependence17,	  18	  and	  delinquent	  behavior	  or	  attention-­‐deficit	  disorder	  in	  children	  or	  adolescents.19,	  20	  	  Whether	  externalizing	  disorders	  during	  development	  convey	  long-­‐term	  risk	  for	  adult	  insomnia	  is	  not	  known.	  	  In	  general,	  the	  extent	  to	  which	  insomnia	  is	  predicted	  by	  early-­‐emerging	  psychopathological	  difficulties	  remains	  unclear.	  In	  this	  study,	  we	  make	  use	  of	  data	  from	  a	  four-­‐decade-­‐long	  New	  Zealand	  birth	  cohort	  to	  examine	  the	  link	  between	  multiple	  mental	  health	  problems	  across	  the	  lifecourse	  –	  including	  both	  internalizing	  and	  externalizing	  disorders	  –	  and	  subsequent	  insomnia	  in	  early	  midlife.	  	  In	  examining	  lifecourse	  mental	  health	  problems,	  we	  focused	  on	  three	  developmental	  periods:	  Childhood,	  when	  behavioral	  problems	  predictive	  of	  later	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psychological	  disorder	  first	  emerge;	  adolescence,	  when	  severe	  cases	  of	  diagnosable	  disorder	  become	  apparent;	  and	  young	  adulthood,	  when	  incidence	  of	  psychological	  disorder	  reaches	  its	  peak	  and	  psychiatric	  problems	  may	  become	  entrenched.	  	  We	  also	  examined	  study	  members’	  familial	  history	  of	  psychological	  disorders,	  which	  can	  serve	  as	  both	  a	  proxy	  for	  genetic	  risk	  and	  as	  a	  useful	  indicator	  of	  clinical	  prognosis.21-­‐23	  	  We	  hypothesized	  that	  internalizing	  disorders	  across	  development	  would	  be	  the	  strongest	  predictors	  of	  adult	  insomnia,	  but	  that	  externalizing	  disorders	  would	  also	  convey	  excess	  insomnia	  risk.	  	  We	  further	  hypothesized	  that	  any	  association	  between	  internalizing	  or	  externalizing	  disorders	  and	  adult	  insomnia	  would	  exhibit	  a	  dose-­‐response	  relationship,	  with	  more	  cumulative	  lifetime	  diagnoses	  predicting	  higher	  insomnia	  risk.	  	  We	  focus	  on	  individuals	  diagnosed	  with	  insomnia	  at	  early	  midlife,	  in	  their	  late	  30s.	  	  People	  between	  35	  and	  45	  have	  some	  of	  the	  highest	  rates	  of	  insomnia	  of	  any	  age	  group.1,	  24	  	  Furthermore,	  midlife	  adults	  are	  consolidating	  their	  careers	  and	  serving	  as	  the	  main	  economic	  provider	  for	  their	  families.	  	  These	  responsibilities	  require	  substantial	  energy	  and	  productivity,	  which	  may	  be	  undermined	  by	  sleeping	  problems.1,	  25	  	  The	  public	  health	  burden	  of	  insomnia	  may	  therefore	  be	  greatest	  among	  people	  in	  their	  30s	  and	  40s.	  	  	  	  
	  
METHODS	  
Sample	  Participants	  are	  members	  of	  the	  Dunedin	  Multidisciplinary	  Health	  and	  Development	  Study,	  a	  longitudinal	  investigation	  of	  health	  and	  behavior	  in	  a	  complete	  birth	  cohort.26	  	  Study	  members	  (N=1,037;	  91%	  of	  eligible	  births;	  52%	  male)	  were	  all	  individuals	  born	  between	  April	  1972	  and	  March	  1973	  in	  Dunedin,	  New	  Zealand,	  who	  were	  eligible	  for	  the	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longitudinal	  study	  based	  on	  residence	  in	  the	  province	  at	  age	  3	  and	  who	  participated	  in	  the	  first	  follow-­‐up	  assessment	  at	  age	  3.	  	  The	  cohort	  represents	  the	  full	  range	  of	  socioeconomic	  status	  in	  the	  general	  population	  of	  New	  Zealand’s	  South	  Island	  and	  is	  primarily	  white.	  Assessments	  were	  carried	  out	  at	  birth	  and	  at	  ages	  3,	  5,	  7,	  9,	  11,	  13,	  15,	  18,	  21,	  26,	  32,	  and,	  most	  recently,	  38	  years,	  when	  95%	  of	  the	  1,007	  study	  members	  still	  alive	  took	  part.	  	  	  	  At	  each	  assessment	  wave,	  study	  members	  are	  brought	  to	  the	  research	  unit	  for	  a	  full	  day	  of	  interviews	  and	  examinations.	  	  The	  Otago	  Ethics	  Committee	  approved	  each	  phase	  of	  the	  study	  and	  informed	  consent	  was	  obtained.	  	  	  	  	  	  
Measures	  Insomnia	  diagnosis.	  	  At	  the	  age-­‐38	  assessment	  in	  2010-­‐2012,	  study	  members	  were	  asked	  how	  often	  they	  had	  problems	  sleeping	  in	  the	  past	  month	  because	  they	  could	  not	  get	  to	  sleep	  within	  30	  minutes,	  woke	  up	  in	  the	  middle	  of	  the	  night,	  woke	  up	  in	  the	  early	  morning,	  or	  felt	  that	  their	  sleep	  was	  unrefreshing.27	  	  Individuals	  were	  diagnosed	  with	  
η͵	  week,	  and	  also	  η͵at	  least	  one	  of	  the	  following	  domains:	  (a)	  work,	  (b)	  ability	  to	  concentrate,	  (c)	  memory,	  (d)	  daytime	  sleepiness,	  (e)	  levels	  of	  energy	  or	  fatigue,	  or	  (f)	  levels	  of	  irritability,27	  or	  (g)	  staying	  awake	  while	  driving,	  eating,	  or	  engaging	  in	  social	  activity.28	  	  This	  definition	  meets	  the	  primary	  diagnostic	  criteria	  for	  insomnia	  according	  to	  the	  then-­‐current	  Diagnostic	  and	  Statistical	  Manual	  of	  Mental	  Disorders-­‐Version	  4	  (DSM-­‐IV);	  however,	  we	  did	  not	  impose	  the	  DSM-­‐IV	  exclusionary	  criteria	  (e.g.,	  presence	  of	  comorbid	  conditions).	  	  
8  
  
Mental	  health	  correlates.	  	  We	  first	  assessed	  cross-­‐sectional	  comorbidity	  between	  insomnia	  and	  other	  psychiatric	  conditions	  at	  age	  38.	  	  We	  then	  assessed	  whether	  antecedent	  mental	  health	  issues	  predicted	  age-­‐38	  insomnia,	  focusing	  on	  the	  three	  key	  developmental	  periods:	  Young	  adulthood	  (ages	  18-­‐32),	  when	  study	  members	  were	  completing	  their	  education	  and	  starting	  their	  careers;	  adolescence	  (ages	  11-­‐15),	  which	  corresponds	  to	  study	  members’	  secondary	  school	  years;	  and	  childhood	  (ages	  5-­‐11),	  which	  corresponds	  to	  study	  members’	  primary	  school	  years.	  	  Sleep	  difficulties	  are	  a	  criterion	  symptom	  in	  some	  psychiatric	  disorders	  (e.g.,	  depression),	  and	  a	  frequent	  complaint	  in	  other	  disorders	  (e.g.	  attention-­‐deficit	  hyperactivity	  disorder).3	  	  Moreover,	  disorders	  at	  age	  38	  may	  be	  a	  continuation	  of	  mental	  health	  problems	  from	  earlier	  in	  life.29,	  30	  	  To	  rule	  out	  these	  potential	  confounds,	  we	  used	  age-­‐38	  concurrent	  disorders	  as	  a	  covariate	  when	  testing	  whether	  antecedent	  mental	  health	  problems	  predict	  early	  midlife	  insomnia.	  	  	  	  
Concurrent	  psychiatric	  conditions.	  	  At	  age	  38,	  psychiatric	  diagnoses	  were	  made	  using	  the	  Diagnostic	  Interview	  Schedule,31,	  32	  following	  the	  DSM-­‐IV	  criteria	  with	  a	  reporting	  period	  of	  12	  months.33	  	  Prevalence	  estimates	  and	  comparisons	  to	  U.S.	  and	  New	  Zealand	  national	  surveys	  have	  been	  previously	  reported.34	  Disorders	  examined	  at	  38	  years	  were	  major	  depression,	  generalized	  anxiety	  disorder,	  any	  fear	  or	  phobia	  (including	  panic	  disorder,	  social	  phobia,	  agoraphobia,	  and	  simple	  phobia),	  post-­‐traumatic	  stress	  disorder	  (PTSD),	  alcohol	  dependence,	  cannabis	  dependence,	  and	  hard	  drug	  dependence.	  	  Hard	  drugs	  included	  stimulants	  (e.g.,	  amphetamines,	  speed),	  sedatives	  (e.g.,	  tranquillizers,	  barbiturates),	  opiates	  (e.g.,	  heroin,	  codeine,	  opium),	  hallucinogens	  (e.g.,	  LSD,	  mescaline),	  inhalants	  (e.g.,	  flue,	  toluene),	  cocaine	  or	  crack,	  or	  being	  on	  methadone	  maintenance.      
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Two	  of	  these	  psychiatric	  disorders,	  depression	  and	  generalized	  anxiety	  disorder	  (GAD),	  include	  sleep	  problems	  among	  the	  diagnostic	  criteria.	  	  Analyses	  examining	  associations	  between	  these	  two	  age-­‐38	  disorders	  and	  insomnia	  were	  re-­‐run	  using	  modified	  diagnostic	  criteria	  that	  excluded	  the	  sleep	  items.	  	  Results	  were	  substantively	  identical	  (estimates	  varied	  by	  less	  than	  4%);	  therefore,	  the	  full	  standard	  diagnostic	  measures	  were	  used	  in	  all	  analyses.	  
Persistent	  psychiatric	  conditions	  in	  young	  adulthood.	  	  In	  community	  cohorts,	  many	  young	  adults	  experience	  psychiatric	  episodes	  that	  occur	  only	  once	  and	  are	  relatively	  mild,	  involve	  little	  impairment,	  and	  are	  unlikely	  to	  prompt	  clinical	  attention.	  	  In	  contrast,	  adult	  individuals	  with	  persistent	  disorder	  are	  considerably	  less	  common,	  and	  tend	  to	  have	  severe	  disorder	  and	  need	  clinical	  intervention.34	  	  For	  this	  reason,	  we	  focus	  on	  the	  occurrence	  of	  persistent	  disorder	  during	  young	  adulthood.	  	  Study	  members	  were	  considered	  to	  have	  a	  persistent	  psychiatric	  condition	  if	  they	  were	  diagnosed	  with	  a	  disorder	  at	  two	  or	  more	  Study	  assessment	  occasions	  across	  ages	  18,	  21,	  26,	  and	  32	  years.	  	  At	  ages	  18	  and	  21,	  disorders	  were	  diagnosed	  according	  to	  DSM-­‐III-­‐R	  criteria.35	  	  At	  ages	  26	  and	  32,	  diagnoses	  were	  made	  following	  DSM-­‐IV	  criteria.	  	  Disorder	  persistence	  analyses	  included	  major	  depression,	  any	  anxiety	  disorder	  (i.e.,	  generalized	  anxiety	  disorder	  (GAD),	  panic	  disorder,	  social	  phobia,	  agoraphobia,	  and	  simple	  phobia),	  alcohol	  dependence,	  and	  cannabis	  dependence.	  (Hard	  drug	  dependence	  and	  PTSD	  were	  only	  assessed	  starting	  at	  age	  26,	  so	  were	  not	  included	  in	  persistence	  analyses.)	    
Psychiatric	  conditions	  in	  adolescence.	  Psychiatric	  diagnoses	  at	  11,	  13,	  and	  15	  years	  of	  age	  were	  assessed	  using	  the	  Diagnostic	  Interview	  Schedule	  for	  Children,36	  following	  the	  then-­‐current	  DSM-­‐III	  criteria.37	  	  Study	  members	  were	  defined	  as	  having	  a	  diagnosis	  during	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adolescence	  if	  they	  met	  criteria	  for	  that	  diagnosis	  at	  any	  of	  these	  assessments.	  	  We	  focused	  on	  single	  diagnoses	  during	  the	  adolescent	  developmental	  period	  because	  individuals	  diagnosed	  with	  psychiatric	  disorder	  during	  the	  adolescent	  period	  are	  rare,	  and	  their	  cases	  tend	  to	  be	  severe	  and	  involve	  substantial	  impairment.34	  Adolescent	  diagnoses	  examined	  for	  this	  analysis	  included	  depression,	  anxiety,	  conduct	  disorder,	  and	  attention	  deficit	  hyperactivity	  disorder	  (ADHD).	  	  Adolescent	  anxiety	  disorders	  diagnosed	  under	  DSM-­‐III	  comprised	  overanxious	  disorder,	  separation	  anxiety	  disorder,	  and	  phobias;	  the	  separate	  disorders	  were	  collapsed	  into	  one	  variable.30	  	  	  
Childhood	  behavioral	  problems.	  	  The	  Rutter	  Child	  Scales38	  were	  administered	  at	  ages	  5,	  7,	  9	  and	  11	  years	  to	  assess	  major	  areas	  of	  each	  participant's	  behavioral	  and	  emotional	  functioning	  during	  the	  past	  year.	  	  Scales	  were	  completed	  separately	  by	  parents	  and	  teachers	  at	  each	  age.	  	  The	  relevant	  items	  were	  summed	  across	  the	  four	  ages	  to	  derive,	  separately	  for	  parents	  and	  teachers,	  measures	  indexing	  the	  study	  participants'	  behavior	  problems	  in	  different	  settings.	  	  These	  indices	  were	  then	  combined	  into	  one	  measure	  for	  each	  behavior	  problem.	  	  The	  three	  final	  measures	  included	  internalizing	  problems	  (e.g.,	  worries	  about	  many	  things,	  often	  appears	  miserable,	  unhappy,	  tearful,	  and	  rather	  solitary),	  antisocial	  behavior	  problems	  (e.g.,	  bullies	  other	  children,	  frequently	  fights	  with	  other	  children,	  often	  irritable,	  disobedient,	  tells	  lies,	  destroys	  own	  or	  others'	  belongings,	  and	  has	  stolen	  things	  on	  one	  or	  more	  occasions),	  and	  hyperactivity	  (e.g.,	  very	  restless	  and	  hardly	  ever	  still,	  squirmy/fidgety,	  cannot	  settle	  into	  anything	  for	  more	  than	  a	  few	  moments,	  has	  poor	  concentration	  or	  short	  attention	  span).	  	  For	  ease	  of	  interpretation,	  each	  of	  the	  three	  measures	  was	  standardized.	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Family	  history	  of	  psychiatric	  disorder.	  	  The	  Dunedin	  Study	  family	  history	  assessment	  has	  been	  described	  in	  detail	  elsewhere.39	  	  The	  family	  history	  consisted	  of	  reports	  of	  psychiatric	  problems	  provided	  by	  study	  members	  and	  both	  parents	  for	  each	  study	  member’s	  siblings,	  parents,	  and	  grandparents,	  using	  the	  Family	  History	  Screen.40	  	  Here,	  we	  report	  family	  history	  for	  major	  depression,	  any	  anxiety	  disorder,	  conduct	  disorder/antisocial	  personality	  disorder	  (CD/ASPD),	  and	  alcohol	  abuse.	  	  The	  family	  history	  was	  summarized	  as	  the	  proportion	  of	  family	  members	  in	  the	  pedigree	  who	  ever	  had	  the	  disorder,	  adjusted	  to	  account	  for	  differences	  in	  genetic	  relatedness	  to	  the	  proband	  of	  first-­‐	  and	  second-­‐degree	  relatives.	  	  For	  ease	  of	  comparison	  across	  disorders,	  family	  history	  scores	  for	  each	  disorder	  were	  standardized.	  Confounding	  factors.	  	  We	  controlled	  for	  sex	  and	  childhood	  social	  class	  in	  all	  multivariate	  analyses.	  	  Study	  members’	  family	  social	  class	  in	  childhood	  was	  measured	  with	  a	  six-­‐point	  scale	  assessing	  parents'	  occupational	  status.41	  	  Family	  social	  class	  is	  defined	  as	  the	  average	  of	  the	  highest	  occupational	  status	  level	  of	  either	  parent	  across	  study	  assessments	  from	  the	  study	  member's	  birth	  through	  15	  years	  (alpha	  =	  .92).	  	  To	  aid	  interpretation,	  we	  use	  standardized	  scores.	  
	  
Statistical	  Analysis	  	  	  We	  used	  Poisson	  regression	  with	  robust	  standard	  errors	  to	  model	  risk	  ratios	  estimating	  associations	  between	  lifetime	  psychiatric	  variables	  and	  adult	  insomnia.	  	  First,	  to	  establish	  the	  degree	  of	  concurrent	  comorbidity	  between	  insomnia	  and	  other	  disorders,	  we	  modeled	  the	  risk	  for	  insomnia	  associated	  with	  each	  age-­‐38	  psychiatric	  diagnosis.	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Unadjusted	  models	  in	  this	  analysis	  included	  no	  covariates;	  adjusted	  models	  controlled	  for	  sex	  and	  family	  social	  class.	  	  We	  next	  assessed	  whether	  antecedent	  mental	  health	  problems	  (i.e.,	  persistent	  psychiatric	  conditions	  in	  young	  adulthood,	  psychiatric	  conditions	  in	  adolescence,	  behavioral	  problems	  in	  childhood,	  and	  family	  history	  of	  disorder)	  predicted	  insomnia	  at	  age	  38.	  	  In	  adjusted	  models	  for	  these	  analyses,	  we	  additionally	  controlled	  for	  psychiatric	  comorbidity	  at	  age	  38.	  	  Concurrent	  psychiatric	  morbidity	  was	  defined	  using	  a	  single	  dichotomous	  covariate	  that	  indexed	  whether	  the	  study	  member	  received	  any	  of	  the	  following	  psychiatric	  diagnoses	  at	  age	  38:	  depression,	  GAD,	  PTSD,	  any	  fear	  or	  phobia,	  alcohol	  dependence,	  cannabis	  dependence,	  or	  hard	  drug	  dependence.	  	  	  Dose-­‐response	  relationships	  between	  cumulative	  lifecourse	  psychiatric	  diagnoses	  and	  age-­‐38	  insomnia	  risk	  were	  estimated	  using	  an	  ordinal	  variable	  corresponding	  to	  number	  of	  diagnoses	  received	  between	  ages	  11	  and	  38	  (e.g.,	  0,	  1,	  2,	  3,	  or	  4+	  diagnoses	  with	  depression);	  again,	  Poisson	  regression	  with	  robust	  standard	  errors	  was	  used	  to	  model	  risk	  ratios	  for	  insomnia.	  	  Lastly,	  we	  used	  interaction	  terms	  to	  test	  whether	  associations	  between	  earlier	  psychiatric	  history	  variables	  and	  age-­‐38	  insomnia	  differed	  for	  men	  and	  women.	  	  All	  statistical	  analyses	  were	  conducted	  using	  Stata	  12.0	  (StataCorp	  LP).	  	  
RESULTS	  Prevalence	  of	  insomnia	  at	  midlife.	  	  	  At	  age	  38	  years,	  19.6	  percent	  of	  Dunedin	  study	  members	  (n=186)	  were	  diagnosed	  with	  insomnia.	  	  	  Study	  members	  with	  insomnia	  were	  more	  likely	  than	  their	  peers	  to	  be	  female	  (59.1%	  vs.	  47.4%;	  F2=	  8.18,	  p=0.004);	  many	  also	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came	  from	  lower-­‐class	  families	  (F(1,942)=5.02,	  p=0.03).	  	  Table	  1	  shows	  descriptive	  statistics	  for	  study	  members	  with	  and	  without	  insomnia.	  	  	   Concurrent	  psychiatric	  conditions	  at	  age	  38.	  	  Table	  2	  shows	  relative	  risks	  between	  specific	  psychiatric	  diagnoses	  and	  insomnia,	  all	  at	  age	  38.	  	  After	  adjustment	  for	  sex	  and	  family	  social	  class,	  study	  members	  with	  depression,	  GAD,	  fear/phobia,	  PTSD,	  alcohol	  dependence,	  or	  cannabis	  dependence	  (but	  not	  hard	  drug	  dependence)	  were	  significantly	  more	  likely	  than	  their	  peers	  to	  have	  insomnia.	  	  Moreover,	  study	  members	  with	  insomnia	  had	  substantially	  higher	  burdens	  of	  overall	  age-­‐38	  psychiatric	  morbidity	  (Figure	  1).	  	  While	  fewer	  than	  12	  percent	  of	  those	  without	  insomnia	  met	  criteria	  for	  two	  or	  more	  concurrent	  psychiatric	  diagnoses,	  nearly	  30	  percent	  of	  insomniac	  individuals	  did	  so.	  	  	   Antecedent	  mental	  health	  problems.	  	  Table	  3	  shows	  relative	  risks	  between	  earlier	  mental	  health	  problems	  and	  age-­‐38	  insomnia.	  	  	  
Persistent	  psychiatric	  conditions	  in	  young	  adulthood	  (ages	  18-­‐32).	  Study	  members	  who	  had	  been	  persistently	  diagnosed	  with	  internalizing	  disorder	  as	  young	  adults	  were	  significantly	  more	  likely	  to	  have	  insomnia	  at	  early	  midlife.	  	  In	  models	  adjusted	  for	  sex,	  social	  class,	  and	  age-­‐38	  psychiatric	  comorbidity,	  young	  adults	  with	  persistent	  depression	  were	  approximately	  40	  percent	  more	  likely	  than	  their	  peers	  to	  have	  subsequent	  midlife	  insomnia,	  while	  young	  adults	  with	  persistent	  anxiety	  were	  60	  percent	  more	  likely	  to	  have	  insomnia.	  	  	  Persistent	  alcohol	  dependence	  did	  not	  predict	  subsequent	  insomnia.	  	  Moreover,	  although	  bivariate	  models	  suggested	  that	  young	  adults	  with	  persistent	  cannabis	  dependence	  were	  also	  at	  higher	  risk	  for	  insomnia,	  in	  adjusted	  models	  this	  association	  was	  attenuated	  and	  became	  non-­‐significant.	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   Psychiatric	  conditions	  in	  adolescence	  (ages	  11-­‐15).	  	  We	  found	  that,	  in	  unadjusted	  models,	  adolescent	  study	  members	  diagnosed	  with	  internalizing	  disorder	  (depression	  or	  anxiety)	  appeared	  significantly	  more	  likely	  than	  their	  peers	  to	  have	  insomnia	  in	  early	  midlife.	  	  After	  adjusting	  for	  covariates,	  however,	  depressed	  adolescents	  no	  longer	  had	  elevated	  risk	  for	  insomnia.	  	  Anxiety	  remained	  a	  significant	  factor:	  Anxious	  adolescents	  were	  46	  percent	  more	  likely	  than	  their	  peers	  to	  be	  subsequently	  diagnosed	  with	  insomnia.	  	  Neither	  conduct	  disorder	  nor	  ADHD	  increased	  risk	  for	  age-­‐38	  insomnia.	  
	   Behavioral	  problems	  in	  childhood	  (ages	  5-­‐11).	  Childhood	  internalizing	  problems	  also	  foreshadowed	  study	  members’	  early	  midlife	  sleeping	  problems.	  	  Study	  members	  who	  were	  rated	  by	  their	  parents	  and	  teachers	  as	  prone	  to	  excessive	  worry,	  misery,	  and	  solitude	  were	  at	  significantly	  increased	  risk	  for	  insomnia;	  after	  adjusting	  for	  covariates,	  a	  one-­‐SD	  increase	  in	  these	  internalizing	  problems	  predicted	  a	  14	  percent	  increased	  risk	  of	  insomnia	  at	  age	  38.	  	  Study	  member	  children	  with	  higher	  levels	  of	  antisocial	  behavior	  or	  hyperactivity	  evinced	  no	  excess	  risk	  for	  insomnia.	  	  	  
	   Family	  history	  of	  psychiatric	  disorder.	  	  In	  unadjusted	  models,	  we	  found	  that	  study	  members	  whose	  families	  had	  more	  severe	  histories	  of	  depression,	  anxiety,	  and	  alcohol	  dependence	  (but	  not	  CD/ASPD)	  were	  more	  likely	  to	  have	  insomnia	  in	  early	  midlife.	  	  In	  models	  adjusted	  for	  sex,	  social	  class,	  and	  age-­‐38	  psychiatric	  comorbidity,	  however,	  only	  family	  history	  of	  internalizing	  disorders	  conveyed	  excess	  risk	  for	  insomnia.	  	  Study	  members	  with	  one-­‐SD	  increases	  in	  familial	  depression	  and	  familial	  anxiety	  were,	  respectively,	  13	  percent	  and	  20	  percent	  more	  likely	  to	  have	  insomnia.	  	  Role	  of	  stability	  of	  internalizing	  problems.	  	  Thus	  far,	  we	  report	  that	  internalizing	  problems	  in	  young	  adulthood,	  adolescence,	  and	  childhood,	  as	  well	  as	  familial	  history	  of	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internalizing	  disorder,	  consistently	  predict	  insomnia	  at	  early	  midlife.	  	  Mental	  health	  problems	  –	  including	  internalizing	  disorder	  –	  exhibit	  considerable	  stability	  over	  the	  lifecourse.29,	  30	  	  It	  might	  therefore	  seem	  inevitable	  that	  internalizing	  problems	  at	  different	  age	  periods	  will	  produce	  similar	  associations	  with	  later	  insomnia,	  simply	  because	  the	  same	  individuals	  have	  anxiety/depression	  at	  each	  age	  (as	  well	  as	  a	  higher	  likelihood	  of	  insomnia).	  	  However,	  additional	  analyses	  suggested	  that	  this	  was	  not	  the	  case	  in	  our	  study.	  	  Correlations	  between	  internalizing	  disorder	  measures	  at	  different	  ages	  were	  significant,	  but	  no	  correlation	  exceeded	  0.26.	  	  This	  indicates	  substantial	  unshared	  variance	  between	  the	  variables	  across	  the	  years.	  	  Therefore,	  it	  was	  not	  simply	  the	  stability	  of	  internalizing	  symptoms	  over	  time	  that	  was	  responsible	  for	  our	  findings.	  	  We	  also	  tested	  whether	  persistent	  internalizing	  disorder	  across	  the	  lifecourse,	  assessed	  using	  a	  variable	  that	  separately	  summed	  the	  number	  of	  depression	  and	  anxiety	  diagnoses	  received	  between	  adolescence	  and	  age	  38,	  predicted	  early	  midlife	  insomnia	  (Figure	  2).	  	  In	  analyses	  adjusting	  for	  sex,	  social	  class,	  and	  age-­‐38	  psychiatric	  comorbidity,	  each	  additional	  occasion	  that	  a	  study	  member	  was	  diagnosed	  with	  depression	  was	  associated	  with	  a	  25	  percent	  increased	  risk	  of	  insomnia	  (RR=1.25,	  95%	  CI=1.15,	  1.36;	  p<0.001);	  each	  additional	  anxiety	  diagnosis	  was	  associated	  with	  a	  19	  percent	  increased	  risk	  of	  insomnia	  (RR=1.19;	  95%	  CI=1.10,	  1.29;	  p<0.001).	  	  	  	   This	  dose-­‐response	  effect	  was	  somewhat	  stronger	  among	  study	  members	  whose	  diagnosable	  depression	  episode	  or	  anxiety	  disorder	  began	  in	  adolescence	  (i.e.,	  between	  ages	  11	  and	  15	  years).	  	  Among	  study	  members	  with	  early-­‐onset	  depression,	  each	  additional	  depression	  diagnosis	  predicted	  a	  nearly	  70%	  increased	  risk	  (RR=1.68;	  95%	  CI=1.12,	  2.53;	  
p=0.013)	  for	  later	  insomnia.	  	  Among	  those	  without	  early-­‐onset	  depression,	  however,	  each	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additional	  depression	  diagnosis	  predicted	  only	  28%	  increased	  risk	  for	  insomnia	  (RR=1.28;	  95%	  CI=1.14,	  1.42;	  p<0.0001).	  	  Similarly,	  among	  study	  members	  with	  early-­‐onset	  anxiety,	  each	  additional	  anxiety	  diagnosis	  predicted	  a	  28%	  increased	  insomnia	  risk	  (RR=1.28;	  95%	  CI=1.11,	  1.47;	  p=0.001);	  but	  for	  those	  individuals	  whose	  anxiety	  began	  later,	  each	  additional	  anxiety	  diagnosis	  was	  associated	  with	  only	  a	  17%	  increase	  (RR=1.17;	  95%	  CI=1.04,	  1.32;	  p=0.008)	  in	  insomnia	  risk.	  	  	   Sex	  differences,	  adulthood	  social	  class,	  medical	  comorbidity,	  and	  presence	  of	  an	  infant	  in	  the	  home.	  	  We	  tested	  whether	  any	  of	  the	  associations	  between	  psychiatric	  history	  variables	  and	  adulthood	  insomnia	  differed	  for	  men	  and	  women.	  	  Except	  for	  the	  association	  between	  concurrent	  PTSD	  and	  insomnia	  in	  Table	  2	  (p	  for	  interaction=0.04),	  none	  of	  the	  sex	  interaction	  terms	  were	  statistically	  significant	  (all	  other	  p>0.15).	  	  We	  also	  tested	  whether	  including	  a	  covariate	  for	  study	  members’	  age-­‐38	  socioeconomic	  status	  (based	  on	  their	  current	  or	  most	  recent	  occupation42)	  made	  a	  difference	  to	  the	  associations	  reported	  in	  Tables	  2	  and	  3;	  results	  were	  unaffected.	  	  	  Because	  physical	  health	  problems	  may	  also	  contribute	  to	  insomnia,	  we	  wanted	  to	  ascertain	  whether	  medical	  comorbidity	  played	  a	  role	  in	  our	  observed	  associations.	  	  To	  test	  this,	  we	  used	  a	  variable	  indexing	  how	  many	  serious	  chronic	  physical	  health	  conditions	  the	  study	  member	  reported	  at	  age	  38	  (mean	  =	  0.48,	  SD	  =	  0.67,	  range	  =	  0	  to	  3).	  	  Health	  conditions	  included	  asthma,	  arthritis,	  cancer,	  Crohn's	  disease,	  hepatitis	  C,	  lupus,	  multiple	  sclerosis,	  and	  obesity	  (defined	  as	  a	  body	  mass	  index	  of	  30	  or	  higher).  	  We	  then	  re-­‐estimated	  each	  model	  in	  Tables	  2	  and	  3	  controlling	  for	  this	  covariate.	  	  Estimates	  were	  very	  slightly	  reduced	  in	  magnitude	  for	  some	  associations,	  but	  statistical	  inference	  was	  unaffected	  in	  all	  cases.	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Lastly,	  we	  wanted	  to	  ensure	  that	  our	  results	  were	  not	  confounded	  by	  study	  members	  who	  had	  problems	  sleeping	  because	  of	  a	  young	  infant	  in	  the	  home.	  	  Many	  sleep	  studies	  recruit	  participants	  who	  have	  self-­‐referred	  to	  a	  clinic	  because	  of	  severe	  problems	  with	  sleeping.	  	  In	  a	  community	  cohort,	  however,	  some	  false-­‐positive	  cases	  of	  insomnia	  might	  arise	  from	  individuals	  with	  an	  infant	  who	  report	  sleeping	  problems.	  	  A	  total	  of	  26	  
ζ͸-­‐38	  data	  collection	  (4.3%	  of	  study	  members	  with	  insomnia	  (n=8);	  2.4%	  of	  those	  without	  insomnia	  (n=18)).	  	  We	  re-­‐estimated	  each	  model	  in	  Table	  3	  with	  an	  additional	  covariate	  indexing	  the	  presence	  of	  an	  infant;	  results	  were	  unchanged.	  	  Results	  also	  remained	  similar	  if	  we	  altered	  the	  infant	  age	  criteria	  to	  15	  or	  24	  months,	  by	  which	  point	  most	  infants	  sleep	  through	  the	  night.43	  	  
DISCUSSION	  	   The	  results	  of	  this	  study	  provide	  evidence	  that	  individuals	  who	  struggle	  with	  lifecourse	  anxiety	  and	  depression	  are	  uniquely	  susceptible	  to	  insomnia	  in	  early	  midlife.	  	  Although	  we	  found	  in	  cross-­‐sectional	  analyses	  that	  study	  members	  with	  both	  externalizing	  and	  internalizing	  disorders	  were	  more	  likely	  to	  report	  insomnia,	  when	  we	  examined	  these	  relationships	  developmentally	  (and	  controlled	  for	  the	  confounds	  of	  sex,	  social	  class,	  and	  age-­‐38	  concurrent	  psychiatric	  comorbidity),	  we	  found	  that	  insomnia	  risk	  was	  foreshadowed	  solely	  by	  study	  members’	  anxiety	  and	  depression.	  	  The	  link	  between	  prior	  internalizing	  disorder	  –	  as	  measured	  in	  young	  adulthood,	  adolescence,	  and	  childhood,	  and	  by	  familial	  history	  –	  and	  midlife	  insomnia	  was	  highly	  consistent,	  emerged	  early	  in	  life,	  and	  followed	  a	  dose-­‐response	  pattern.	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Methodological	  advantages	  of	  the	  study	  include	  its	  use	  of	  a	  representative	  birth	  cohort	  with	  good	  retention,	  a	  rigorous	  operational	  definition	  of	  insomnia,4	  and	  our	  prospective	  measures	  of	  multiple	  mental	  health	  problems	  spanning	  nearly	  40	  years.	  	  The	  study	  was	  also	  strengthened	  by	  the	  inclusion	  of	  study	  members’	  family	  history	  of	  psychiatric	  disorder.	  	  	  There	  were	  several	  limitations	  to	  this	  study.	  	  First,	  the	  reporting	  period	  for	  insomnia	  at	  age	  38	  was	  one	  month,	  whereas	  it	  was	  12	  months	  for	  the	  other	  disorders.	  	  It	  was	  therefore	  not	  possible	  to	  establish	  the	  temporal	  ordering	  of	  insomnia	  and	  concurrent	  psychiatric	  diagnoses	  at	  age	  38.	  	  In	  addition,	  more	  detailed	  measures	  of	  our	  study	  members’	  sleep	  habits	  (such	  as	  sleep	  logs	  and	  overnight	  sleep	  studies),	  as	  well	  as	  information	  on	  the	  presence	  of	  sleep	  disorders	  such	  as	  narcolepsy	  or	  sleep	  apnea,	  were	  not	  available.	  	  We	  also	  found	  that	  19.6%	  of	  the	  Dunedin	  study	  members	  met	  criteria	  for	  a	  past-­‐month	  diagnosis	  of	  insomnia.	  	  This	  is	  higher	  than	  some	  previous	  estimates,	  in	  part	  due	  to	  different	  assessment	  methods.	  	  However,	  the	  prevalence	  of	  insomnia	  in	  our	  population-­‐representative	  cohort	  was	  largely	  consistent	  with	  that	  found	  in	  samples	  of	  North	  American	  adults.1-­‐3,	  44	  	  Our	  definition	  of	  insomnia	  is	  in	  line	  with	  the	  insomnia	  diagnoses	  outlined	  by	  both	  DSM-­‐IV	  and	  DSM-­‐V,	  with	  the	  caveat	  that	  we	  inquired	  about	  sleep	  problems	  lasting	  at	  least	  one	  month	  (rather	  than	  three	  months	  as	  required	  by	  DSM-­‐V)	  because	  this	  DSM-­‐V	  criterion	  was	  established	  subsequent	  to	  our	  age-­‐38	  data	  assessment.	  	  Additionally,	  our	  insomnia	  assessment	  did	  not	  include	  queries	  about	  the	  frequency	  of	  insomnia	  episodes	  (e.g.,	  number	  of	  episodes	  in	  the	  past	  year)	  or	  the	  age	  of	  onset	  of	  study	  members’	  insomnia	  symptoms.	  	  This	  would	  have	  required	  assessing	  long-­‐term	  retrospective	  recall	  of	  symptoms,	  which	  has	  previously	  been	  found	  to	  be	  highly	  unreliable.34	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The	  chicken-­‐or-­‐the-­‐egg	  question	  of	  whether	  insomnia	  antedates	  psychiatric	  disorder	  or	  disorder	  antedates	  insomnia	  has	  long	  been	  under	  debate.8-­‐10,	  14,	  45	  	  Our	  paper	  cannot	  settle	  this	  debate	  because	  insomnia	  symptoms	  have	  not	  been	  regularly	  assessed	  alongside	  psychiatric	  disorders	  in	  prior	  waves	  of	  the	  Dunedin	  study.	  	  The	  study	  design	  to	  settle	  this	  question	  would	  entail	  contiguous	  annual	  assessments	  of	  both	  insomnia	  and	  mental	  disorders	  in	  a	  cohort	  as	  they	  age	  from	  childhood	  to	  midlife.	  	  However,	  it	  is	  our	  experience	  that	  neither	  funders	  nor	  research	  participants	  favor	  this	  approach.	  	  What	  our	  study	  contributes	  is	  the	  observation	  that	  the	  association	  emerges	  with	  the	  earliest	  childhood	  symptoms	  of	  disorder	  (and	  even	  goes	  back	  over	  two	  generations	  of	  family	  history	  of	  internalizing	  disorder),	  and	  that	  among	  psychiatric	  conditions,	  anxiety	  and	  depression	  are	  the	  most	  important	  to	  examine	  in	  future	  research.	  	  	  Previous	  work	  has	  suggested	  that	  the	  most	  robust	  association	  between	  insomnia	  and	  psychological	  disorder	  is	  with	  depression,3,	  14,	  46	  although	  strong	  longitudinal	  links	  between	  anxiety	  and	  sleep	  problems	  have	  also	  been	  reported	  (e.g.,	  7,	  15,	  47).	  	  Our	  longitudinal	  analyses	  suggested	  that	  the	  magnitudes	  of	  the	  associations	  between	  midlife	  insomnia	  and	  lifecourse	  depression	  and	  anxiety	  were	  similar.	  	  It	  is	  possible	  that	  depression	  and	  anxiety	  predict	  insomnia	  for	  different	  reasons,	  but	  the	  overall	  similarity	  between	  the	  anxiety	  and	  depression	  findings	  is	  not	  surprising	  given	  the	  high	  degree	  of	  longitudinal	  comorbidity	  between	  these	  disorders	  and	  their	  many	  shared	  etiological	  factors.30,	  48,	  49	  	  	  We	  found	  that	  histories	  of	  persistent	  alcohol	  or	  cannabis	  dependence	  in	  young	  adulthood	  were	  not	  associated	  with	  later	  insomnia.	  	  While	  the	  physiological	  effects	  of	  alcohol	  and	  cannabis	  appear	  to	  have	  an	  acute	  contemporaneous	  influence	  on	  sleep	  problems,	  and	  while	  sleep	  problems	  may	  predict	  subsequent	  relapse	  in	  recovering	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alcoholics,50,	  51	  our	  study	  of	  early	  midlife	  adults	  suggests	  that	  alcohol	  and	  cannabis	  dependence	  are	  not	  aspects	  of	  individuals’	  lifecourse	  histories	  that	  need	  to	  be	  considered	  as	  predisposing	  to	  insomnia.	  	  It	  is	  possible,	  however,	  that	  as	  the	  cohort	  ages,	  a	  longitudinal	  bidirectional	  link	  between	  insomnia	  and	  alcohol	  dependence	  will	  emerge.	  	  However,	  insomnia	  does	  not	  consistently	  predict	  subsequent	  incidence	  of	  substance	  dependence,	  suggesting	  that	  the	  cross-­‐sectional	  associations	  may	  be	  more	  important.52,	  53	  Our	  findings	  have	  implications	  for	  understanding	  the	  etiology	  of	  insomnia.	  	  Disturbances	  in	  key	  physiological	  systems	  could	  underpin	  lifelong	  and	  intergenerational	  susceptibility	  to	  both	  internalizing	  disorders	  and	  sleep	  problems.	  	  Our	  finding	  that	  insomnia	  risk	  was	  especially	  high	  among	  individuals	  who	  had	  family	  history	  of	  internalizing	  disorder,	  as	  well	  as	  among	  those	  with	  an	  early-­‐onset	  and	  persistent	  course	  of	  internalizing	  disorder,	  is	  consistent	  with	  this	  notion	  of	  shared	  genetic	  and	  biological	  susceptibility.54-­‐56	  	  Candidate	  physiological	  disturbances	  could	  include	  hyperarousal	  of	  neural,	  cardiac,	  metabolic,	  and/or	  neuroendocrine	  systems,57-­‐60	  and	  dysregulation	  of	  the	  noradrenergic	  or	  synaptic	  systems.61-­‐63	  	  	  Alternatively,	  it	  is	  also	  possible	  that	  the	  association	  between	  internalizing	  disorder	  across	  the	  lifecourse	  and	  midlife	  insomnia	  arises	  from	  cognitive	  and	  behavioral	  conditioning	  processes.	  	  For	  example,	  experiencing	  sleep	  difficulties	  in	  the	  context	  of	  a	  major	  depressive	  episode	  may	  alter	  an	  individual’s	  later	  perceptions	  of	  his	  or	  her	  sleep	  environment,	  generating	  anticipatory	  anxious	  rumination	  and	  ‘‘learned	  sleep	  preventing	  associations’’57	  which	  can	  lead	  to	  chronic	  insomnia.64	  	  Future	  research	  should	  further	  test	  these	  two	  hypotheses.	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Lastly,	  our	  findings	  also	  have	  implications	  for	  treating	  insomnia	  in	  clinical	  populations	  and	  for	  ameliorating	  the	  public	  health	  burden	  due	  to	  insomnia.	  	  Clinically,	  our	  study	  adds	  to	  the	  evidence	  that	  adults	  suffering	  from	  insomnia	  are	  likely	  to	  have	  a	  history	  of	  depression	  and	  anxiety.	  	  This	  knowledge	  can	  help	  with	  clinicians’	  case	  conceptualization	  of	  people	  seeking	  treatment	  for	  insomnia.	  	  It	  also	  indicates	  that	  comorbid	  internalizing	  disorders	  may	  need	  to	  be	  treated	  in	  conjunction	  with	  the	  sleeping	  problems	  in	  order	  to	  best	  address	  patients’	  complaints.	  	  From	  a	  public	  health	  perspective,	  the	  high	  prevalence	  of	  insomnia	  observed	  among	  our	  study	  participants	  lends	  support	  to	  the	  conclusion	  that	  adulthood	  insomnia	  is	  a	  common	  and	  burdensome	  disorder	  in	  its	  own	  right.1,	  3,	  65	  	  Given	  the	  significance	  of	  sleep	  difficulties	  for	  multiple	  areas	  of	  functioning,	  it	  may	  be	  worthwhile	  providing	  these	  individuals	  with	  information	  and	  skills	  –	  such	  as	  stress	  management	  interventions	  and	  sleep	  promotion	  techniques	  –	  that	  help	  prevent	  symptoms	  of	  insomnia.	  	  The	  recognition	  that	  individuals	  who	  experience	  persistent	  internalizing	  problems	  during	  development	  are	  at	  high	  risk	  for	  insomnia	  in	  later	  adulthood	  may	  also	  inform	  prevention	  strategies	  at	  the	  population	  level.	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Table 1. Sociodemographic characteristics and psychiatric history variables in Dunedin study members with and without 
insomnia at age 38 
 
No insomnia diagnosis 
(n=763)  
Insomnia diagnosis 
(n=186)  p 
Covariates      
 Gender, n (%) female 362 (47.4%)  110 (59.1%)  0.004 
 Family social class, birth-15, standardized mean (SD) 0.06 (0.98)  -0.13 (1.05)  0.025 
Concurrent psychiatric diagnoses (age 38)      
 Major depression, n (%) 88 (11.6%)  67 (36.0%)  <0.001 
 GAD, n (%) 28 (3.7%)  26 (14.0%)  <0.001 
 Any fear or phobia, n (%) 111 (14.6%)  49 (26.6%)  <0.001 
 PTSD, n (%) 17 (2.2%)  18 (9.7%)  <0.001 
 Alcohol dependence, n (%) 66 (8.7%)  25 (13.5%)  0.046 
 Cannabis dependence, n (%) 27 (3.6%)  12 (6.5%)  0.074 
 Hard drug dependence, n (%) 22 (2.9%)  7 (3.8%)  0.536 
Persistent (2+) psychiatric diagnoses in young adulthood (ages 18-32)       
 Major depression, n (%) 110 (14.4%)  51 (27.7%)  <0.001 
 Any persistent anxiety disorder, n (%) * 101 (13.2%)  56 (30.4%)  <0.001 
 Alcohol dependence, n (%) 90 (11.8%)  27 (14.7%)  0.287 
 Cannabis dependence, n (%) 54 (7.1%)  22 (12.0%)  0.029 
Psychiatric diagnoses in adolescence (ages 11-15)      
 Major depression, n (%) 37 (5.0%)  16 (9.0%)  0.040 
 Anxiety disorder, n (%) 130 (17.6%)  54 (30.5%)  <0.0001 
 Conduct disorder, n (%) 124 (16.8%)  34 (19.2%)  0.447 
 ADHD, n (%) 43 (5.8%)  12 (6.8%)  0.632 
Behavioral problems in childhood (ages 5-11)      
 Internalizing problems, standardized mean (SD) -0.06 (0.98)  0.20 (1.03)  0.002 
 Antisocial behavior problems, standardized mean (SD) -0.05 (0.94)  0.11 (1.17)  0.064 
 Hyperactivity, standardized mean (SD) -0.03 (0.96)  0.03 (1.00)  0.456 
Family history of psychiatric disorder      
 Major depression, standardized mean (SD) -0.04 (0.99)  0.19 (0.99)  0.005 
 Any anxiety disorder, standardized mean (SD) -0.06 (0.94)  0.24 (1.17)  0.0002 
 CD/ASPD, standardized mean (SD) -0.02 (0.96)  0.11 (1.13)  0.103 
 Alcohol abuse, standardized mean (SD) -0.05 (0.96)  0.17 (1.13)  0.009 
* Includes GAD, panic disorder, social phobia, agoraphobia, and simple phobia. 




Table 2. Psychiatric diagnoses at age 38 and risk for concurrent insomnia 
  Unadjusted Model  Adjusted Model a 
  Risk Ratio 95% CI p  Risk Ratio 95% CI p 
Major depression  2.88 (2.25, 3.68) <0.001  2.70 (2.11, 3.47) <0.001 
GAD  2.69 (1.97, 3.67) <0.001  2.56 (1.88, 3.49) <0.001 
Any fear or phobia b  1.77 (1.34, 2.35) <0.001  1.65 (1.23, 2.21) 0.001 
PTSD  2.81 (1.98, 3.98) <0.001  2.44 (1.68, 3.53) <0.001 
Alcohol dependence  1.47 (1.02, 2.11) 0.038  1.55 (1.08, 2.22) 0.017 
Cannabis dependence  1.61 (0.98, 2.62) 0.058  1.76 (1.05, 2.95) 0.032 
Hard drug dependence  1.24 (0.64, 2.39) 0.525  1.23 (0.62, 2.45) 0.553 
           
Statistically significant (p<0.05) risk ratios are shown in bold font. 
Abbreviations: GAD, generalized anxiety disorder; PTSD, post-traumatic stress disorder. 
a Includes covariates for sex and family social class. 




Figure	  1.	  Insomnia	  diagnosis	  status	  and	  psychiatric	  comorbidity	  at	  age	  38	  years.	  	  Bars	  depict,	  among	  study	  members	  with	  age-­‐38	  insomnia	  (dark	  gray	  bars)	  and	  without	  age-­‐38	  insomnia	  (light	  gray	  bars)ǡǡǡǡη͵concurrent	  psychiatric	  conditions	  (including	  major	  depression,	  generalized	  anxiety	  disorder,	  any	  fear	  or	  phobia,	  post-­‐traumatic	  stress	  disorder,	  alcohol	  dependence,	  cannabis	  dependence,	  and	  hard	  drug	  dependence).	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Table 3. History of psychiatric problems and risk for insomnia at age 38 
 Unadjusted Model  Adjusted Model a 
  Risk Ratio  95% CI p  Risk Ratio 95% CI p 
Persistent (2+) psychiatric diagnoses in 
young adulthood (ages 18-32)   
 Persistent major depression 1.87 (1.42, 2.46) <0.001  1.42 (1.07, 1.88) 0.017 
 Any persistent anxiety disorder b 2.20 (1.69, 2.87) <0.001  1.63 (1.24, 2.15) 0.001 
 Persistent alcohol dependence 1.22 (0.85, 1.75) 0.279  1.07 (0.75, 1.52) 0.722 
 Persistent cannabis dependence 1.56 (1.07, 2.27) 0.022  1.30 (0.87, 1.94) 0.207 
Psychiatric diagnoses in adolescence 
(ages 11-15)  
 Major depression 1.62 (1.05, 2.49) 0.030  1.23 (0.83, 1.82) 0.295 
 Anxiety 1.74 (1.32, 2.30) <0.001  1.46 (1.11, 1.92) 0.007 
 Conduct disorder 1.14 (0.82, 1.59) 0.443  0.98 (0.70, 1.36) 0.888 
 ADHD 1.14 (0.68, 1.91) 0.627  1.06 (0.65, 1.74) 0.810 
Behavioral problems in childhood  
(ages 5-11) c  
 Internalizing problems 1.21 (1.08, 1.36) 0.001  1.14 (1.01, 1.28) 0.031 
 Antisocial behavior problems 1.12 (0.99, 1.26) 0.067  1.08 (0.95, 1.22) 0.240 
 Hyperactivity 1.05 (0.92, 1.19) 0.451  1.02 (0.90, 1.17) 0.739 
Family history of psychiatric disorder c  
 Family history of major depression 1.20 (1.06, 1.34) 0.003  1.13 (1.00, 1.28) 0.048 
 Family history of anxiety disorder 1.25 (1.12, 1.41) <0.001  1.20 (1.07, 1.35) 0.002 
 Family history of CD/ASPD 1.11 (0.98, 1.26) 0.112  1.01 (0.88, 1.15) 0.924 
 Family history of alcohol abuse 1.17 (1.05, 1.30) 0.006  1.06 (0.94, 1.19) 0.355 
  
Statistically significant (p<0.05) risk ratios are shown in bold font. 
Abbreviations: ADHD, attention-deficit hyperactivity disorder; CD/ASPD, conduct disorder/antisocial personality disorder; GAD, 
generalized anxiety disorder; PTSD, post-traumatic stress disorder. 
a Includes covariates for sex, family social class, and any psychiatric diagnosis received at age 38 (i.e., any of: depression, GAD, 
PTSD, any fear or phobia, alcohol dependence, cannabis dependence, or hard drug dependence). 
b Includes persistent GAD, panic disorder, social phobia, agoraphobia, and/or simple phobia.  
c Exposure variables are standardized  continuous scores; risk ratios for behavioral problems in childhood and family history variables 
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